Delivery Order SPE2DB22D3301-SPE2DB25FY0DB

Award Date 2/14/25
Potential Completion Date 2/18/25
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,725.74 firm fixed-price contract is for the supply of Vancomycin HCL 1.25 gram vials, a critical antibiotic medication. The contract has a period of performance through February 14, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,166.24 issued by the Defense Logistics Agency (DLA) for 4,566,963,078 units of Vancomycin HCL 2 gram vials. The order has a firm fixed price and a completion date of January 17, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $77,188.28 Firm Fixed Price Delivery Order is for the supply of 10 vials of 1 gram Vancomycin, a critical antibiotic medication. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a comprehensive vehicle for providing a range...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4565911028 - VANCOMYCIN 1 GRAM/200 ML BAG 200ML, a critical pharmaceutical product. The award ceiling value is $1,943.10 and the ultimate completion date is September 24, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to various federal agencies, including the DLA, which is a...
This federal contract award, with the ID SPE2DB22D3301|SPE2DB25FX4ME, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,009.16, is for the delivery of VANCOMYCIN 1 GRAM/200 ML BAG 200ML, a critical pharmaceutical product. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award is for the delivery of Vancomycin 1 gram/200 ml bags to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The award has a ceiling value of $1,384.82 and is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary...
This delivery order for vancomycin hydrochloride 1.5 gram vials was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation, located in Conshohocken, Pennsylvania. The firm fixed price order has a potential value of five hundred eighty dollars and requires delivery by September 27, 2023. No set-aside designation was applied to this procurement conducted under an unspecified agency-wide contract vehicle held by Amerisourcebergen. The Defense Logistics Agency manages the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of medical vials. The contract has a ceiling value of $1,624.00 and a period of performance ending on September 13, 2024. This contract is not set aside for any specific business type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
The Defense Logistics Agency awarded a $174 delivery order to Amerisourcebergen Drug Corp for 1.5 gram/300 ml bags of vancomycin. The firm fixed price order is for vancomycin medication to be delivered to a location in Conshohocken, Pennsylvania by September 28, 2023. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation, which will perform as the prime contractor. The order was awarded on September 27, 2023 and does not have a set-aside designation. The Defense Logistics...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,197.98, is for the procurement of DALVANCE 500 MG VIALS. It is a Firm Fixed Price Delivery Order contract with a completion date of May 14, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY0DB
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 5 gram vials of Vancomycin HCL. The contract has a ceiling value of $3,626.31 and an ultimate completion date of February 18, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation indicated.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/16/25, 11:53 AM